Airsonett AB is a Swedish research-based medical technology company which, with its unique technology, leads the way in the development of non-pharmaceutical treatment for allergic asthma.
Airsonett AB has a comprehensive patent portfolio and invests heavily in clinical research and product development. With strong owners, including SEB Venture Capital, Industrifonden and Magnus Lundberg, Airsonett is also investing in international growth.
The company was founded in the mid-1990s as part of a company that specialised in industrial clean room technology. TLA (Temperature controlled Laminar Airflow) technology, on which Airsonett’s products are based, evolved from industrial clean room technology. Airsonett AB was hived off into an independent company in 2000. The company’s main product is a non-pharmaceutical asthma treatment called Airsonett.